The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors
about
mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in miceA systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasionGermline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humansNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesThe Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25MicroRNAs as growth regulators, their function and biomarker status in colorectal cancerInsights into Regulation of the miR-17-92 Cluster of miRNAs in CancerThe MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potentialMYC and the art of microRNA maintenanceMicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cellsThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseMicroRNAs in stress signaling and human diseaseMicroRNAs and their isomiRs function cooperatively to target common biological pathwaysDesign of a small molecule against an oncogenic noncoding RNAMYC on the path to cancerMicro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAsSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancerRole of the miR-17∼92 cluster family in cerebellar and medulloblastoma development.The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 clusterMicroRNA regulation network in colorectal cancer metastasisThe miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplificationp53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancersClinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser.Colorectal cancer migration and invasion initiated by microRNA-106aMicroRNA miR-92a-1 biogenesis and mRNA targeting is modulated by a tertiary contact within the miR-17~92 microRNA clusterMicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Large-scale modeling of condition-specific gene regulatory networks by information integration and inference.Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage.Shielding the messenger (RNA): microRNA-based anticancer therapies.MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.Revisiting the matricellular concept.Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation.Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA
P2860
Q23915560-3CA3D209-CA1C-470E-BD7A-DC4345460DA4Q24633772-8CE209B4-9643-411C-B601-CE83DA8AC75BQ24635323-56AD66DD-4217-44C7-A7A7-30E746AC4943Q26748881-B62C521E-6452-4D4B-AED7-02346D7F7240Q26748969-FDAA7D9F-EFD0-4584-B344-824C91F70B3FQ26775610-3594B57E-02E3-4CA3-B43C-2723ACE004EBQ26781049-EC5F81DB-9E87-42A9-BC13-44744DD20861Q26797469-569E1989-C526-4A77-B025-92A1BD832AC5Q26825457-99A8FA96-6D18-4A87-8959-CED14663FDC6Q26865287-41057B12-BC04-460D-A1EA-561BE358F289Q27015587-FC78F969-9816-4D16-8310-AE810E60F99AQ27027517-2407D972-8280-4827-A8E7-EB8A40744D8BQ27499590-3DE5451B-66BE-4EA2-907C-D337E624DAECQ28829505-4BB048FF-8B42-49E6-B94B-830090669810Q29619979-7B03146E-862D-449F-BC35-2F29B78D0F7BQ30405560-B9B80F76-BD27-4935-B4D9-C5340B00C718Q33592822-833E8D5A-2006-489A-93C2-6D7D41AE838CQ33742561-D3996D5C-B8BE-4D4E-ABBE-44E3FA36C526Q33862088-CF886F2E-4EE2-4237-BB3B-8E56677FA425Q34049023-248E2940-716D-48C7-A287-E70644F25803Q34067225-55E431C1-C5CC-424E-A21D-057758AF8D86Q34131951-FD6A875F-A3C9-4825-AD3C-B8DF8F3D1BCAQ34150285-3018AF0E-44C7-4624-89D7-91AD1EB1B487Q34161573-1854FC85-8772-4E32-819A-CC63706BD567Q34181123-2F74739F-BF86-4432-9047-DA0C3FD53CEFQ34227513-76661148-A5F8-4783-A6E8-1561AFB06425Q34295029-F59E38D3-3017-480A-B5EB-22B2DA96EE41Q34389634-8350011A-5163-4B86-B275-7282A440F0CFQ34403761-75AC2556-7723-4C83-8856-26548176D01CQ34409620-4CA571A6-3EAB-4481-9056-3B9F0B948D6FQ34579800-735624A7-601C-4245-90B6-8D00664E5282Q34702270-5ACFA017-AD4C-439A-9681-D136BA55E929Q34990488-ACFD69EC-C16E-4679-877E-DD71DFD19C59Q35070602-A32CF5D2-24AA-4A6A-8A36-9CC9FD3CB602Q35145398-B72D8BB8-4C01-4D1F-99B9-6F14BDDF483FQ35233858-238651DA-7DD6-4AF9-8645-C19C4133D335Q35543478-F9BBB8EB-DB94-4139-A6B2-189F9700F58BQ35553324-62BFBAAF-8C79-48F2-B3DC-5E524A79F104Q35554311-3C8D434D-788B-49C7-99C0-944807BAFDF3Q36110907-A935BFC6-11B0-470A-8B49-B61444CBAFF9
P2860
The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@ast
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@en
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@nl
type
label
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@ast
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@en
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@nl
prefLabel
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@ast
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@en
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@nl
P2093
P2860
P3181
P1433
P1476
The myc-miR-17~92 axis blunts ...... pendent antiangiogenic factors
@en
P2093
Andrei Thomas-Tikhonenko
Emma Furth
Gregory H Enders
Jamie L Fox
Janell M Schelter
Michael Dews
Michele A Cleary
Prema Sundaram
Stacy Hultine
Wafik El-Deiry
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-10-2412
P407
P577
2010-10-15T00:00:00Z